Plus   Neg

DICK'S Sporting To Eliminate All Single-use Plastic Bags By 2025 - Quick Facts

Omni-channel sporting goods retailer DICK'S Sporting Goods, Inc. (DKS) announced Tuesday two major actions to help create a future free of single-use plastic bags.

It has committed to remove all single-use point-of-sale plastic bags from its stores by 2025 and a partnership with Closed Loop Partners' Center for the Circular Economy.

Single-use plastic bags are typically made from fossil fuel-derived virgin plastic and are among the top 10 items found on beaches and waterways worldwide.

DICK'S has been working to reduce its environmental footprint with a recycling rate of 70% for its retail stores and operations.

DICK'S has now joined the 'Consortium to Reinvent the Retail Bag' of leading retailers to identify, test and implement sustainable solutions to replace single-use plastic bags through the Beyond the Bag Initiative. Founding partners include CVS Health, Target and Walmart, as well as Kroger and Walgreens.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. tech giant Google is laying the groundwork for a fiber-optic network that will connect the first time through Saudi Arabia and Israel, opening a new global internet traffic corridor, the Wall Street Journal reported, citing people familiar with the plans. The link would be established as part of an optical-fiber cable line connecting Europe with India. U.S. retailers Best Buy Co. Inc., Abercrombie & Fitch Co., and Dollar Tree Inc. on Tuesday reported results for the third quarter that surpassed analysts' expectations. The upbeat results indicate that retailers have largely recovered from the impact of the coronavirus pandemic just as the holiday season approaches. The companies have also intensified their focused on digital sales. The U.S. Food and Drug Administration approved the first drug to treat primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder which causes recurrent kidney stones and loss of kidney function. Alnylam Pharmaceuticals' Oxlumo (lumasiran) in the form of injection lowers urinary oxalate levels in pediatric and adult patients.
Follow RTT